Regeneron Pharmaceuticals EPS (earnings per share) 1990–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Regeneron Pharmaceuticals's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 18.45 USD, up 35.5% on the same quarter a year before. Regeneron Pharmaceuticals's diluted earnings per share over the last twelve months were 45.26 USD, up 8.4% on the twelve months before. In fiscal year 2025 they were 41.48 USD, up 8.2% on the year before.
Last updated 6 Nov 2026 · Next report 28 Jan 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 45.26 | +8.38% | 46.95 |
| FY2025 | 31 Dec 2025 | 41.48 | +8.19% | 43.07 |
| FY2024 | 31 Dec 2024 | 38.34 | +10.27% | 40.90 |
| FY2023 | 31 Dec 2023 | 34.77 | -9.03% | 37.05 |
| FY2022 | 31 Dec 2022 | 38.22 | -46.89% | 40.51 |
| FY2021 | 31 Dec 2021 | 71.97 | +135.81% | 76.40 |
| FY2020 | 31 Dec 2020 | 30.52 | +65.33% | 32.65 |
| FY2019 | 31 Dec 2019 | 18.46 | -13.29% | 19.38 |
| FY2018 | 31 Dec 2018 | 21.29 | +105.90% | 21.29 |
| FY2017 | 31 Dec 2017 | 10.34 | +34.29% | 11.27 |
| FY2016 | 31 Dec 2016 | 7.70 | +39.49% | 8.55 |
| FY2015 | 31 Dec 2015 | 5.52 | +85.23% | 6.17 |
| FY2014 | 31 Dec 2014 | 2.98 | -19.89% | 3.36 |
| FY2013 | 31 Dec 2013 | 3.72 | -44.89% | 4.23 |
| FY2012 | 31 Dec 2012 | 6.75 | — | 7.92 |
| FY2011 | 31 Dec 2011 | -2.45 | — | -2.45 |
| FY2010 | 31 Dec 2010 | -1.26 | — | -1.26 |
| FY2009 | 31 Dec 2009 | -0.85 | — | -0.85 |
| FY2008 | 31 Dec 2008 | -1.05 | — | -1.05 |
| FY2007 | 31 Dec 2007 | -1.59 | — | -1.59 |
| FY2006 | 31 Dec 2006 | -1.77 | — | -1.77 |
| FY2005 | 31 Dec 2005 | -1.71 | -331.08% | -1.71 |
| FY2004 | 31 Dec 2004 | 0.74 | — | 0.75 |
| FY2003 | 31 Dec 2003 | -2.13 | — | -2.13 |
| FY2002 | 31 Dec 2002 | -2.83 | — | -2.83 |
| FY2001 | 31 Dec 2001 | -1.81 | — | -1.81 |
| FY2000 | 31 Dec 2000 | -0.66 | — | -0.66 |
| FY1999 | 31 Dec 1999 | -0.73 | — | -0.74 |
| FY1998 | 31 Dec 1998 | -0.28 | — | -0.28 |
| FY1997 | 31 Dec 1997 | -0.40 | — | -0.40 |
| FY1996 | 31 Dec 1996 | -1.32 | — | -1.32 |
| FY1995 | 31 Dec 1995 | -1.19 | — | -1.19 |
| FY1994 | 31 Dec 1994 | -1.62 | — | -1.62 |
| FY1993 | 31 Dec 1993 | -2.41 | — | -2.41 |
| FY1992 | 31 Dec 1992 | -1.24 | — | -1.24 |
| FY1991 | 31 Dec 1991 | -0.29 | — | -0.29 |
| FY1990 | 31 Dec 1990 | -0.21 | — | -0.21 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 18.45 | +35.46% | 19.16 |
| Q2 FY2026 | 30 Jun 2026 | 12.20 | -4.76% | 12.59 |
| Q1 FY2026 | 31 Mar 2026 | 6.75 | -7.15% | 6.99 |
| Q4 FY2025 | 31 Dec 2025 | 7.86 | -2.48% | 8.21 |
| Q3 FY2025 | 30 Sept 2025 | 13.62 | +18.02% | 14.09 |
| Q2 FY2025 | 30 Jun 2025 | 12.81 | +3.22% | 13.24 |
| Q1 FY2025 | 31 Mar 2025 | 7.27 | +15.95% | 7.58 |
| Q4 FY2024 | 31 Dec 2024 | 8.06 | -20.90% | 8.53 |
| Q3 FY2024 | 30 Sept 2024 | 11.54 | +29.81% | 12.40 |
| Q2 FY2024 | 30 Jun 2024 | 12.41 | +46.00% | 13.25 |
| Q1 FY2024 | 31 Mar 2024 | 6.27 | -12.55% | 6.70 |
| Q4 FY2023 | 31 Dec 2023 | 10.19 | -2.95% | 10.88 |
| Q3 FY2023 | 30 Sept 2023 | 8.89 | -23.76% | 9.48 |
| Q2 FY2023 | 30 Jun 2023 | 8.50 | +13.79% | 9.05 |
| Q1 FY2023 | 31 Mar 2023 | 7.17 | -16.72% | 7.64 |
| Q4 FY2022 | 31 Dec 2022 | 10.50 | -46.67% | 11.19 |
| Q3 FY2022 | 30 Sept 2022 | 11.66 | -18.63% | 11.66 |
| Q2 FY2022 | 30 Jun 2022 | 7.47 | -73.29% | 7.47 |
| Q1 FY2022 | 31 Mar 2022 | 8.61 | -14.67% | 8.61 |
| Q4 FY2021 | 31 Dec 2021 | 19.69 | +92.29% | 20.99 |
| Q3 FY2021 | 30 Sept 2021 | 14.33 | +93.91% | 15.37 |
| Q2 FY2021 | 30 Jun 2021 | 27.97 | +267.54% | 29.51 |
| Q1 FY2021 | 31 Mar 2021 | 10.09 | +85.82% | 10.58 |
| Q4 FY2020 | 31 Dec 2020 | 10.24 | +47.76% | 10.90 |
| Q3 FY2020 | 30 Sept 2020 | 7.39 | +26.11% | 7.98 |
| Q2 FY2020 | 30 Jun 2020 | 7.61 | +352.98% | 8.19 |
| Q1 FY2020 | 31 Mar 2020 | 5.43 | +36.09% | 5.69 |
| Q4 FY2019 | 31 Dec 2019 | 6.93 | -3.08% | 7.25 |
| Q3 FY2019 | 30 Sept 2019 | 5.86 | +13.35% | 6.12 |
| Q2 FY2019 | 30 Jun 2019 | 1.68 | -65.15% | 1.77 |
| Q1 FY2019 | 31 Mar 2019 | 3.99 | -4.09% | 4.23 |
| Q4 FY2018 | 31 Dec 2018 | 7.15 | +379.87% | 7.58 |
| Q3 FY2018 | 30 Sept 2018 | 5.17 | +55.72% | 5.51 |
| Q2 FY2018 | 30 Jun 2018 | 4.82 | +44.31% | 5.12 |
| Q1 FY2018 | 31 Mar 2018 | 4.16 | +92.59% | 4.44 |
| Q4 FY2017 | 31 Dec 2017 | 1.49 | -31.96% | 1.62 |
| Q3 FY2017 | 30 Sept 2017 | 3.32 | +46.26% | 3.64 |
| Q2 FY2017 | 30 Jun 2017 | 3.34 | +97.63% | 3.66 |
| Q1 FY2017 | 31 Mar 2017 | 2.16 | +35.85% | 2.36 |
| Q4 FY2016 | 31 Dec 2016 | 2.19 | +63.43% | 2.41 |
| Q3 FY2016 | 30 Sept 2016 | 2.27 | +24.73% | 2.53 |
| Q2 FY2016 | 30 Jun 2016 | 1.69 | 0.00% | 1.88 |
| Q1 FY2016 | 31 Mar 2016 | 1.59 | +140.91% | 1.74 |
| Q4 FY2015 | 31 Dec 2015 | 1.34 | +69.62% | 1.49 |
| Q3 FY2015 | 30 Sept 2015 | 1.82 | +149.32% | 2.04 |
| Q2 FY2015 | 30 Jun 2015 | 1.69 | +98.82% | 1.89 |
| Q1 FY2015 | 31 Mar 2015 | 0.66 | +8.20% | 0.74 |
| Q4 FY2014 | 31 Dec 2014 | 0.79 | +8.22% | 0.89 |
| Q3 FY2014 | 30 Sept 2014 | 0.73 | -41.60% | 0.83 |
| Q2 FY2014 | 30 Jun 2014 | 0.85 | +7.59% | 0.96 |
| Q1 FY2014 | 31 Mar 2014 | 0.61 | -32.22% | 0.69 |
| Q4 FY2013 | 31 Dec 2013 | 0.73 | -82.86% | 0.73 |
| Q3 FY2013 | 30 Sept 2013 | 1.25 | -27.33% | 1.44 |
| Q2 FY2013 | 30 Jun 2013 | 0.79 | +12.86% | 0.89 |
| Q1 FY2013 | 31 Mar 2013 | 0.90 | +718.18% | 1.02 |
| Q4 FY2012 | 31 Dec 2012 | 4.26 | — | 4.92 |
| Q3 FY2012 | 30 Sept 2012 | 1.72 | — | 2.02 |
| Q2 FY2012 | 30 Jun 2012 | 0.70 | — | 0.81 |
| Q1 FY2012 | 31 Mar 2012 | 0.11 | — | 0.12 |
| Q4 FY2011 | 31 Dec 2011 | -0.57 | — | -0.58 |
| Q3 FY2011 | 30 Sept 2011 | -0.68 | — | -0.68 |
| Q2 FY2011 | 30 Jun 2011 | -0.69 | — | -0.69 |
| Q1 FY2011 | 31 Mar 2011 | -0.49 | — | -0.49 |
| Q4 FY2010 | 31 Dec 2010 | -0.17 | — | -0.17 |
| Q3 FY2010 | 30 Sept 2010 | -0.41 | — | -0.41 |
| Q2 FY2010 | 30 Jun 2010 | -0.31 | — | -0.31 |
| Q1 FY2010 | 31 Mar 2010 | -0.38 | — | -0.38 |
| Q4 FY2009 | 31 Dec 2009 | -0.45 | — | -0.46 |
| Q3 FY2009 | 30 Sept 2009 | -0.01 | — | -0.01 |
| Q2 FY2009 | 30 Jun 2009 | -0.19 | — | -0.19 |
| Q1 FY2009 | 31 Mar 2009 | -0.22 | — | -0.22 |
| Q4 FY2008 | 31 Dec 2008 | -0.40 | — | -0.40 |
| Q3 FY2008 | 30 Sept 2008 | -0.27 | — | -0.27 |
| Q2 FY2008 | 30 Jun 2008 | -0.23 | — | -0.23 |
| Q1 FY2008 | 31 Mar 2008 | -0.15 | — | -0.15 |
| Q4 FY2007 | 31 Dec 2007 | -0.17 | — | -0.17 |
| Q3 FY2007 | 30 Sept 2007 | -0.54 | — | -0.54 |
| Q2 FY2007 | 30 Jun 2007 | -0.41 | — | -0.41 |
| Q1 FY2007 | 31 Mar 2007 | -0.46 | — | -0.46 |
| Q4 FY2006 | 31 Dec 2006 | -0.47 | — | -0.47 |
| Q3 FY2006 | 30 Sept 2006 | -0.48 | — | -0.48 |
| Q2 FY2006 | 30 Jun 2006 | -0.41 | — | -0.41 |
| Q1 FY2006 | 31 Mar 2006 | -0.36 | — | -0.36 |
| Q4 FY2005 | 31 Dec 2005 | -0.52 | -728.02% | -0.53 |
| Q3 FY2005 | 30 Sept 2005 | -0.62 | — | -0.62 |
| Q2 FY2005 | 30 Jun 2005 | -0.48 | — | -0.48 |
| Q1 FY2005 | 31 Mar 2005 | -0.07 | -106.97% | -0.07 |
| Q4 FY2004 | 31 Dec 2004 | 0.08 | — | 0.08 |
| Q3 FY2004 | 30 Sept 2004 | -0.20 | — | -0.20 |
| Q2 FY2004 | 30 Jun 2004 | -0.26 | — | -0.26 |
| Q1 FY2004 | 31 Mar 2004 | 1.06 | — | 1.17 |
| Q4 FY2003 | 31 Dec 2003 | -0.35 | — | -0.35 |
| Q3 FY2003 | 30 Sept 2003 | -0.52 | — | -0.52 |
| Q2 FY2003 | 30 Jun 2003 | -0.58 | — | -0.58 |
| Q1 FY2003 | 31 Mar 2003 | -0.68 | — | -0.68 |
| Q4 FY2002 | 31 Dec 2002 | -0.81 | — | -0.81 |
| Q3 FY2002 | 30 Sept 2002 | -0.75 | — | -0.75 |
| Q2 FY2002 | 30 Jun 2002 | -0.69 | — | -0.69 |
| Q1 FY2002 | 31 Mar 2002 | -0.58 | — | -0.58 |
| Q4 FY2001 | 31 Dec 2001 | -0.65 | — | -0.65 |
| Q3 FY2001 | 30 Sept 2001 | -0.46 | — | -0.46 |
| Q2 FY2001 | 30 Jun 2001 | -0.34 | — | -0.34 |
| Q1 FY2001 | 31 Mar 2001 | -0.35 | — | -0.35 |
| Q4 FY2000 | 31 Dec 2000 | -0.26 | — | -0.26 |
| Q3 FY2000 | 30 Sept 2000 | -0.09 | — | -0.09 |
| Q2 FY2000 | 30 Jun 2000 | -0.08 | — | -0.08 |
| Q1 FY2000 | 31 Mar 2000 | -0.23 | — | -0.23 |
| Q4 FY1999 | 31 Dec 1999 | -0.04 | — | -0.05 |
| Q3 FY1999 | 30 Sept 1999 | -0.16 | — | -0.16 |
| Q2 FY1999 | 30 Jun 1999 | -0.25 | -457.14% | -0.25 |
| Q1 FY1999 | 31 Mar 1999 | -0.29 | — | -0.29 |
| Q4 FY1998 | 31 Dec 1998 | -0.18 | -1,000.00% | -0.18 |
| Q3 FY1998 | 30 Sept 1998 | -0.04 | — | -0.04 |
| Q2 FY1998 | 30 Jun 1998 | 0.07 | — | 0.07 |
| Q1 FY1998 | 31 Mar 1998 | -0.12 | — | -0.12 |
| Q4 FY1997 | 31 Dec 1997 | 0.02 | — | 0.02 |
| Q3 FY1997 | 30 Sept 1997 | -0.06 | — | -0.06 |
| Q2 FY1997 | 30 Jun 1997 | -0.16 | — | -0.16 |
| Q1 FY1997 | 31 Mar 1997 | -0.23 | — | -0.23 |
| Q4 FY1996 | 31 Dec 1996 | -0.32 | — | -0.32 |
| Q3 FY1996 | 30 Sept 1996 | -0.35 | — | -0.35 |
| Q2 FY1996 | 30 Jun 1996 | -0.31 | — | -0.31 |
| Q1 FY1996 | 31 Mar 1996 | -0.35 | — | -0.35 |
| Q4 FY1995 | 31 Dec 1995 | -0.35 | — | -0.35 |
| Q3 FY1995 | 30 Sept 1995 | -0.37 | — | -0.37 |
| Q2 FY1995 | 30 Jun 1995 | -0.22 | — | -0.22 |
| Q1 FY1995 | 31 Mar 1995 | -0.22 | — | -0.22 |
| Q4 FY1994 | 31 Dec 1994 | -0.30 | — | -0.30 |
| Q3 FY1994 | 30 Sept 1994 | -0.21 | — | -0.21 |
| Q2 FY1994 | 30 Jun 1994 | -0.54 | — | -0.54 |
| Q1 FY1994 | 31 Mar 1994 | -0.57 | — | -0.57 |
| Q4 FY1993 | 31 Dec 1993 | -0.69 | — | -0.69 |
| Q3 FY1993 | 30 Sept 1993 | -0.58 | — | -0.58 |
| Q2 FY1993 | 30 Jun 1993 | -0.61 | — | -0.61 |
| Q1 FY1993 | 31 Mar 1993 | -0.61 | — | -0.61 |
| Q4 FY1992 | 31 Dec 1992 | -0.42 | — | -0.42 |
| Q3 FY1992 | 30 Sept 1992 | -0.38 | — | -0.38 |
| Q2 FY1992 | 30 Jun 1992 | -0.24 | — | -0.24 |
| Q1 FY1992 | 31 Mar 1992 | -0.21 | — | -0.21 |
| Q4 FY1991 | 31 Dec 1991 | -0.14 | — | -0.14 |
| Q3 FY1991 | 30 Sept 1991 | -0.06 | — | -0.06 |
| Q2 FY1991 | 30 Jun 1991 | -0.02 | — | -0.02 |
| Q1 FY1991 | 31 Mar 1991 | -0.07 | — | -0.07 |
| Q4 FY1990 | 31 Dec 1990 | -0.06 | — | -0.06 |
| Q3 FY1990 | 30 Sept 1990 | -0.16 | — | -0.16 |
| Q2 FY1990 | 30 Jun 1990 | -0.16 | — | -0.16 |
| Q1 FY1990 | 31 Mar 1990 | -0.15 | — | -0.15 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Regeneron Pharmaceuticals's EPS
Source: Financial Modeling Prep
